Oocyte maturation pathway

The **oocyte maturation pathway** encompasses a complex network of molecular events that regulate the process by which a fully grown, immature oocyte resumes meiosis and matures, ultimately becoming competent for fertilization. This process is tightly controlled by hormonal triggers, principally the luteinizing hormone (LH) surge, and involves communication between surrounding granulosa/cumulus cells and the oocyte itself[2][5][6][7][8]. Signal transduction through receptors for maturation-inducing hormones (MIH)—progesterone in most vertebrates—activates intricate molecular cascades within the oocyte, particularly involving the formation and activation of **maturation promoting factor (MPF)**, a complex of cyclin B and CDK1 kinase[3][5][6][7]. MPF activation initiates germinal vesicle breakdown (GVBD), chromosome condensation, spindle formation, and orderly segregation of chromosomes in meiosis[1][3][5][6][7]. Additional key regulators in this pathway include kinases such as Mos, the mitogen-activated protein kinase (MAPK/ERK) pathway, calcium signaling, and epigenetic regulators like histone deacetylases (HDACs)[2][5][6][8]. The integrity of the oocyte maturation pathway is essential for successful reproduction; defects can result in developmental arrest or infertility[2][6][7]. **Note: "Oocyte maturation pathway" is not a single, specific molecule, receptor, or canonical drug target, but rather a cellular signaling and regulatory pathway. As such, it is not classified as a therapeutic target (receptor, enzyme, etc.), and a more precise entry would typically focus on a key component within the pathway, such as "Cyclin-dependent kinase 1" (CDK1), "Maturation promoting factor" (MPF), or "Mos kinase." The retrieved literature describes the pathway and critical molecular players, not a single target entity[1][3][7][8].**